TARO-DEFERASIROX (TYPE J) TABLET Kanada - angleščina - Health Canada

taro-deferasirox (type j) tablet

taro pharmaceuticals inc - deferasirox - tablet - 360mg - deferasirox 360mg - heavy metal antagonists

Ferasiro 90 Film-coated tablet Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ferasiro 90 film-coated tablet

boston oncology arabia, saudi arabia - deferasirox - film-coated tablet - 90 mg

Ferasiro 180 Film-coated tablet Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ferasiro 180 film-coated tablet

boston oncology arabia, saudi arabia - deferasirox - film-coated tablet - 180 mg

Ferasiro 360 Film-coated tablet Saudova Arabija - angleščina - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

ferasiro 360 film-coated tablet

boston oncology arabia, saudi arabia - deferasirox - film-coated tablet - 360 mg

Ferupantil 90 mg film-coat. tabl. Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ferupantil 90 mg film-coat. tabl.

sandoz sa-nv - deferasirox 90 mg - film-coated tablet - 90 mg - deferasirox 90 mg - deferasirox

Ferupantil 180 mg film-coat. tabl. Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ferupantil 180 mg film-coat. tabl.

sandoz sa-nv - deferasirox 180 mg - film-coated tablet - 180 mg - deferasirox 180 mg - deferasirox

Ferupantil 360 mg film-coat. tabl. Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ferupantil 360 mg film-coat. tabl.

sandoz sa-nv - deferasirox 360 mg - film-coated tablet - 360 mg - deferasirox 360 mg - deferasirox

DEFIROX 125 MG Izrael - angleščina - Ministry of Health

defirox 125 mg

dexcel ltd, israel - deferasirox - dispersible tablets - deferasirox 125 mg - deferasirox - defirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). defirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 µg/l). lic is the preferred method of iron overload determination and should be used wherever available

DEFIROX 250 MG Izrael - angleščina - Ministry of Health

defirox 250 mg

dexcel ltd, israel - deferasirox - dispersible tablets - deferasirox 250 mg - deferasirox - defirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). defirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 µg/l). lic is the preferred method of iron overload determination and should be used wherever available

DEFIROX 500 MG Izrael - angleščina - Ministry of Health

defirox 500 mg

dexcel ltd, israel - deferasirox - dispersible tablets - deferasirox 500 mg - deferasirox - defirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and pediatric patients (aged 2 years and over). defirox is also indicated for the treatment of chronic iron overload in patients with non-transfusion-dependent thalassemia syndromes aged 10 years and older. chelation therapy should only be initiated when there is evidence of iron overload (liver iron concentration [lic] ≥5 mg fe/g dry weight [dw] or serum ferritin consistently >800 µg/l). lic is the preferred method of iron overload determination and should be used wherever available